IONIS PHARMACEUTICALS INC (IONS) › Cash & EquivalentsIONIS PHARMACEUTICALS INC (IONS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $138.61M2008: $223.99M2009: $105.25M2010: $70.05M2011: $65.48M2012: $124.48M2013: $159.97M2014: $143.00M2015: $128.80M2016: $84.69M2017: $129.63M2018: $278.82M2019: $683.29M2020: $397.66M2021: $869.19M2022: $276.47M2023: $399.27M2024: $242.08M2025: $372.26M$372.26M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$372.26M+53.8%2024$242.08M-39.4%2023$399.27M+44.4%2022$276.47M-68.2%2021$869.19M+118.6%2020$397.66M-41.8%2019$683.29M+145.1%2018$278.82M+115.1%2017$129.63M+53.1%2016$84.69M-34.2%2015$128.80M-9.9%2014$143.00M-10.6%2013$159.97M+28.5%2012$124.48M+90.1%2011$65.48M-6.5%2010$70.05M-33.4%2009$105.25M-53.0%2008$223.99M+61.6%2007$138.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share